Literature DB >> 20026323

Enhanced levels of soluble and membrane-bound CD137 levels in patients with acute coronary syndromes.

Liu Dongming1, Lu Zuxun, Xu Liangjie, Wang Biao, Yang Ping.   

Abstract

BACKGROUND: Increasing evidence shows that costimulatory molecules of the tumor necrosis factor superfamily such as CD40/CD40 ligand and OX40/OX40 ligand have been implicated in atherosclerosis. We investigated whether the expression levels of the tumor necrosis factor superfamily members CD137 in serum and membrane-bound were related to acute coronary syndromes (ACS).
METHODS: Thirty normal controls and 210 patients, including 70 with stable angina (SA), 80 with unstable angina (UA), and 60 with acute myocardial infarction (AMI), were enrolled in our study. The expression of CD137 in peripheral monocytes was analyzed by flow cytometry. Serum soluble CD137 (sCD137) and C-reactive protein levels were measured by commercially available ELISA.
RESULTS: The expression of CD137 in peripheral monocytes in patients with UA [14.2+/-3.5 mean fluorescence intensity (MFI)] and AMI (15.1+/-4.4MFI) was significantly higher than those in patients with SA (6.5+/-2.4MFI) and controls (7.1+/-3.5MFI). sCD137 in patients with UA (16.7+/-4.9 ng/ml) and AMI (19.1+/-4.3 ng/ml) were significantly higher than those in patients with SA (3.4+/-1.4 ng/ml) and controls (3.9+/-1. 3 ng/ml) (p<0.001). C-reactive protein level in serum in patients with UA (13.8+/-3.3 ng/ml) and AMI (15.5+/-4.7 ng/ml) were also higher than those in patients with SA (1.4+/-0.4 ng/ml) and controls (1.3+/-0.3ng/ml). It was interesting that percutaneous transluminal coronary angioplasty (PTCA) induced a marked rise in sCD137 levels in SA patients, while CD137 expression in peripheral monocytes showed no difference between SA patients with PTCA before and after. A positive correlation was found between sCD137 and serum C-reactive protein levels (r=0.681; p<0.0001).
CONCLUSION: Patients with ACS showed increased soluble and membrane-bound CD137 expression. sCD137 level showed a significantly positive correlation with CRP level in patients with ACS. The relation between sCD137 and ACS needs further researches. Copyright 2009 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20026323     DOI: 10.1016/j.cca.2009.12.011

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  12 in total

1.  Increased Peripheral CD137 Expression in a Mouse Model of Permanent Focal Cerebral Ischemia.

Authors:  Xiao-Qing Li; Yang-Yang Wang; Ting-Ting Yang; Yi-Ning Qian; He Yin; Shan-Shan Zhong; Rong A; Yang He; Bao-Lei Xu; Guang-Zhi Liu
Journal:  Cell Mol Neurobiol       Date:  2019-02-18       Impact factor: 5.046

2.  Levels of 4-1BB transcripts and soluble 4-1BB protein are elevated in the adipose tissue of human obese subjects and are associated with inflammatory and metabolic parameters.

Authors:  T H Tu; C-S Kim; J-H Kang; I S Nam-Goong; C W Nam; E S Kim; Y I Kim; J I Choi; T Kawada; T Goto; T Park; J H Yoon Park; M-S Choi; R Yu
Journal:  Int J Obes (Lond)       Date:  2013-11-27       Impact factor: 5.095

Review 3.  T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword.

Authors:  Karin H Simons; Alwin de Jong; J Wouter Jukema; Margreet R de Vries; Ramon Arens; Paul H A Quax
Journal:  Nat Rev Cardiol       Date:  2019-06       Impact factor: 32.419

Review 4.  Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis.

Authors:  A C Foks; J Kuiper
Journal:  Br J Pharmacol       Date:  2017-05-04       Impact factor: 8.739

Review 5.  The role of costimulatory receptors of the tumour necrosis factor receptor family in atherosclerosis.

Authors:  Ricardo F Antunes; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  J Biomed Biotechnol       Date:  2011-12-22

6.  Loss of intraepidermal nerve fiber density during SIV peripheral neuropathy is mediated by monocyte activation and elevated monocyte chemotactic proteins.

Authors:  Jessica R Lakritz; Jake A Robinson; Michael J Polydefkis; Andrew D Miller; Tricia H Burdo
Journal:  J Neuroinflammation       Date:  2015-12-18       Impact factor: 8.322

Review 7.  The Roles of CD137 Signaling in Atherosclerosis.

Authors:  In-Hyuk Jung; Goo Taeg Oh
Journal:  Korean Circ J       Date:  2016-10-20       Impact factor: 3.243

Review 8.  Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation.

Authors:  Jin Dai; Pu Fang; Jason Saredy; Hang Xi; Cueto Ramon; William Yang; Eric T Choi; Yong Ji; Wei Mao; Xiaofeng Yang; Hong Wang
Journal:  J Hematol Oncol       Date:  2017-07-24       Impact factor: 17.388

9.  Clinical implications of elevated serum soluble CD137 levels in patients with acute coronary syndrome.

Authors:  Jinchuan Yan; Cuiping Wang; Rui Chen; Haibing Yang
Journal:  Clinics (Sao Paulo)       Date:  2013       Impact factor: 2.365

10.  Increased Soluble CD137 Levels and CD4+ T-Cell-Associated Expression of CD137 in Acute Atherothrombotic Stroke.

Authors:  Yang He; Dong-Hui Ao; Xiao-Qing Li; Shan-Shan Zhong; Rong A; Yang-Yang Wang; Ya-Juan Xiang; Bao-Lei Xu; Ting-Ting Yang; Xu-Guang Gao; Guang-Zhi Liu
Journal:  Clin Transl Sci       Date:  2018-04-26       Impact factor: 4.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.